SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-307937
Filing Date
2022-12-19
Accepted
2022-12-19 08:46:34
Documents
13
Period of Report
2022-12-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d414069d8k.htm   iXBRL 8-K 28749
2 EX-4.1 d414069dex41.htm EX-4.1 46617
  Complete submission text file 0001193125-22-307937.txt   208532

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qtnt-20221215.xsd EX-101.SCH 2860
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qtnt-20221215_lab.xml EX-101.LAB 17927
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qtnt-20221215_pre.xml EX-101.PRE 11244
7 EXTRACTED XBRL INSTANCE DOCUMENT d414069d8k_htm.xml XML 3445
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Filer) CIK: 0001596946 (see all company filings)

IRS No.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-36415 | Film No.: 221469708
SIC: 2835 In Vitro & In Vivo Diagnostic Substances